It's actually quite difficult to find out what Study 6 entails....

It's actually quite difficult to find out what Study 6 entails. I've had a look at the last couple of presentations and whilst they say that Study 6 is to be completed this year they don't explain what needs to be done. My impression is that study 6 is about producing the commercial test kit to be used in Study 7 (study 7 being about using that test kit on 1,000 people and comparing those results with those from FIT testing and colonoscopies). So if they are starting to line up people to be included in Study 7 it means that they are at least progressing with Study 6. But I'm guessing there.

Also, as chiRal has pointed out , it is interesting that a unit of Sonic Healthcare is involved in Study 7. Lou Panaccio is a non-executive director of both Rhythm Biosciences and Sonic Healthcare.

The results for Study 7 are not due out until towards the end of this calendar year so until then any share price activity will likely need to be powered by hopium.